AstraZeneca on Sunday said it had conducted a review of people vaccinated with its COVID-19 vaccine and found no evidence of an increased risk of blood clots.
The review covered more than 17 million people vaccinated in the European Union and United Kingdom and came after several countries have suspended their rollouts of the AstraZeneca vaccine.